These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37097695)
1. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review. Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695 [TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature. Taira F; Horimoto Y; Saito M Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376 [TBL] [Abstract][Full Text] [Related]
3. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. Baudon C; Duhoux FP; Sinapi I; Canon JL J Med Case Rep; 2016 Jun; 10():178. PubMed ID: 27312594 [TBL] [Abstract][Full Text] [Related]
4. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature. Baeksgaard L; Sørensen JB Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435 [TBL] [Abstract][Full Text] [Related]
5. A case of disseminated intravascular coagulation following tumour lysis syndrome due to small cell carcinoma of the lung. Takahashi S; Takehara T; Tani T; Ishioka K; Madoiwa S Respirol Case Rep; 2023 Mar; 11(3):e01093. PubMed ID: 36776994 [TBL] [Abstract][Full Text] [Related]
6. Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer. Yahata T; Nishikawa N; Aoki Y; Tanaka K Gynecol Oncol; 2006 Nov; 103(2):752-4. PubMed ID: 16857250 [TBL] [Abstract][Full Text] [Related]
7. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer. Gouveia HS; Lopes SO; Faria AL BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434 [TBL] [Abstract][Full Text] [Related]
8. [Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis]. Kawaguchi Ushio A; Hattori M; Kohno N; Kaise H; Iwata H Gan To Kagaku Ryoho; 2013 Nov; 40(11):1529-32. PubMed ID: 24231708 [TBL] [Abstract][Full Text] [Related]
9. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase. Bose P; Qubaiah O J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203 [TBL] [Abstract][Full Text] [Related]
10. [Tumour lysis syndrome in small-cell lung cancer]. Boshuizen RC; Smit AA; Moons-Pasic A; Bresser P Ned Tijdschr Geneeskd; 2016; 160():A9823. PubMed ID: 27334081 [TBL] [Abstract][Full Text] [Related]
11. Tumour lysis syndrome in a patient with intravascular spread from a recurrent epithelial ovarian cancer. Camarata M; Davies R; Copley S; Blagden S BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23616333 [TBL] [Abstract][Full Text] [Related]
12. Ixazomib-associated tumor lysis syndrome in multiple myeloma: A case report. Jin F; Yang M; Chen Y; Jiang L; Liu L Medicine (Baltimore); 2020 Nov; 99(45):e22632. PubMed ID: 33157919 [TBL] [Abstract][Full Text] [Related]
13. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study. Takai M; Yamauchi T; Ookura M; Matsuda Y; Tai K; Kishi S; Yoshida A; Iwasaki H; Nakamura T; Ueda T Anticancer Res; 2014 Dec; 34(12):7287-96. PubMed ID: 25503162 [TBL] [Abstract][Full Text] [Related]
14. [A case of bone marrow carcinomatosis with disseminated intravascular coagulation arising from breast cancer successfully treated with paclitaxel plus bevacizumab]. Kawai H; Sugimoto R; Miyauchi S; Yoshida R; Waki N; Hirayama S; Ishizaki M; Nishi H; Yamashita K Gan To Kagaku Ryoho; 2014 Nov; 41(12):1957-9. PubMed ID: 25731388 [TBL] [Abstract][Full Text] [Related]
15. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Nitz U; Gluz O; Graeser M; Christgen M; Kuemmel S; Grischke EM; Braun M; Augustin D; Potenberg J; Krauss K; Schumacher C; Forstbauer H; Reimer T; Stefek A; Fischer HH; Pelz E; Zu Eulenburg C; Kates R; Wuerstlein R; Kreipe HH; Harbeck N; Lancet Oncol; 2022 May; 23(5):625-635. PubMed ID: 35405088 [TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome in metastatic breast cancer after a single dose of paclitaxel. Vaidya GN; Acevedo R Am J Emerg Med; 2015 Feb; 33(2):308.e1-2. PubMed ID: 25178848 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis. Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846 [TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature. Drakos P; Bar-Ziv J; Catane R Am J Clin Oncol; 1994 Dec; 17(6):502-5. PubMed ID: 7977169 [TBL] [Abstract][Full Text] [Related]
19. Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature. Carrier X; Gaur S; Philipovskiy A Am J Case Rep; 2020 Sep; 21():e925248. PubMed ID: 32934194 [TBL] [Abstract][Full Text] [Related]
20. [HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report]. Senoo S; Mannami T; Tamura T; Fujiwara N; Ikeda G; Komoda M; Ohtawa Y; Fujimoto Y; Sato N; Kambara T; Waku T; Kenmotsu M; Kurimoto E; Okada T; Harita S; Sonobe H Gan To Kagaku Ryoho; 2015 Dec; 42(13):2471-5. PubMed ID: 26809307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]